Cantitate/Preț
Produs

Advances in Chronic Lymphocytic Leukemia: Advances in Experimental Medicine and Biology, cartea 792

Editat de Sami Malek
en Limba Engleză Paperback – 23 aug 2016
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course.  While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL.  In this book, CLL experts have contributed state-of-the-art summaries of various important aspects of CLL biology and have discussed the translational implication of such findings.  This book, which is directed at physicians and researchers alike, aims to educate broadly and deeply.  Intentionally, the many aspects and nuances of CLL clinical care that can only really be appreciated through direct patient care are not covered here, but instead, the book presents basic aspects of CLL that underlie many of the contemporary decisions that are made in CLL research and clinical settings.

We hope that this book will critically inform the community and stimulate interest in CLL, which will ultimately translate into better CLL research, prognostication and therapy, with the end goal of providing a better outlook for patients afflicted with this common leukemia.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 106549 lei  6-8 săpt.
  Springer – 23 aug 2016 106549 lei  6-8 săpt.
Hardback (1) 107844 lei  6-8 săpt.
  Springer – 7 sep 2013 107844 lei  6-8 săpt.

Din seria Advances in Experimental Medicine and Biology

Preț: 106549 lei

Preț vechi: 112157 lei
-5% Nou

Puncte Express: 1598

Preț estimativ în valută:
20391 21450$ 17014£

Carte tipărită la comandă

Livrare economică 09-23 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781493953899
ISBN-10: 1493953893
Pagini: 348
Ilustrații: XI, 334 p. 25 illus., 24 illus. in color.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.49 kg
Ediția:Softcover reprint of the original 1st ed. 2013
Editura: Springer
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:New York, NY, United States

Cuprins

Preface.- B-cell receptor and antigens in CLL.- The CLL cell microenvironment.- Acquired genomic copy number aberrations in CLL.- Recurrent gene mutations in CLL.- TP53 aberrations in CLL.- Gene expression and epigenetic deregulation.- Apoptosis deregulation in CLL.- Richter’s Syndrome.- Molecular biomarkers in chronic lymphocytic leukemia.- Critical Signal Transduction Pathways in CLL.- Immunotherapies in CLL.- Novel therapeutic agents in CLL.- Inherited susceptibility to CLL.- miR deregulations in CLL.- Index.

Notă biografică

Sami N. Malek is an Associate Professor at the Department of Internal Medicine at the University of Michigan Health System. Dr. Malek's research interests include basic and translational questions in Leukemia and Lymphoma. Well known in the field of CLL, Dr. Malek is well-published in the area and is invited to international conferences and seminars to give talks on the topic.

Textul de pe ultima copertă

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course.  While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL.  In this book, CLL experts have contributed state-of-the-art summaries of various important aspects of CLL biology and have discussed the translational implication of such findings.  This book, which is directed at physicians and researchers alike, aims to educate broadly and deeply.  Intentionally, the many aspects and nuances of CLL clinical care that can only really be appreciated through direct patient care are not covered here, but instead, the book presents basic aspects of CLL that underlie many of the contemporary decisions that are made in CLL research and clinical settings.

We hope that this book will critically inform the community and stimulate interest in CLL, which will ultimately translate into better CLL research, prognostication and therapy, with the end goal of providing a better outlook for patients afflicted with this common leukemia. 

Caracteristici

Provides a comprehensive review on chronic lymphocytic leukemia Features paramount research in the field Focuses on crucial aspects of CLL pathogenesis Includes supplementary material: sn.pub/extras